Examining the significance of robustness for the clinical use of blood-based biomarkers

E-Learning - Module 4

 

Advancing diagnostics for Alzheimer's disease

E-Learning - Module 4

 

Advancing diagnostics for Alzheimer's disease

 

Examining the significance of robustness for the clinical use of blood-based biomarkers

 

Please be aware this module is hosted on the AD/PD Education ™ website and you will need to set up a free account to start your learning journey.

Visit Module

Advancing diagnostics for Alzheimer's disease is an interactive educational programme that explores the future Alzheimer’s disease diagnostic pathway, the clinical value of CSF biomarkers and how they can support the timely diagnosis of Alzheimer’s disease.

This educational module has been developed for Alzheimer’s clinicians and specialists with insights from leading expert, Professor Henrik Zetterberg from the University of Gothenburg.

Key topics covered in the module are:

  • The potential clinical value of blood-based biomarkers (BBBMs)
  • The significance of robustness for clinical assays
  • Advancements in the development of robust BBBMs

 

Advancing diagnostics for Alzheimer's disease is brought to you in colloboration with AD/PD™ Education

 

 

 

 

Visit AD/PD Education

 

 

 

© 2024 F. Hoffmann-La Roche Ltd. M-XX-00016029 Date of preparation: January 2024

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

I am a healthcare professional

Not a healthcare professional? Browse:

Roche's patients website Roche.com

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

Leave Site Stay on Medically